ICG to acquire a 40% stake in Prosur at a €1.1bn valuation.

Synopsis

ICG, a private equity firm, agreed to acquire a 40% stake in Prosur, a pioneering food biotech business, at a €1.1bn valuation.

Principals

Prosur

Intermediate Capital Group (icg)

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

deloitte

HQ - London

legal advisors

target

1600

Deals

£ 434.13 B

Total Value

a&o shearman

HQ - New York

legal advisors

bidder

325

Deals

£ 159.10 B

Total Value

az capital

HQ - Madrid, Spain

financial advisors

bidder

Deals

£ 68.51 B

Total Value